OTCMKTS:ITHUF iAnthus Capital (ITHUF) Stock Price, News & Analysis $0.0050 0.00 (-16.67%) As of 02:05 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesSEC FilingsShort InterestBuy This Stock About iAnthus Capital Stock (OTCMKTS:ITHUF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get iAnthus Capital alerts:Sign Up Key Stats Today's Range$0.0048▼$0.006150-Day Range N/A52-Week Range$0.0030▼$0.0194Volume1.93 million shsAverage Volume451,141 shsMarket CapitalizationN/AP/E Ratio0.03Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers cannabis flower and trims, such as packaged flowers and pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. iAnthus Capital Holdings, Inc. was founded in 2014 and is headquartered in Toronto, Canada. Read More iAnthus Capital Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks18th Percentile Overall ScoreITHUF MarketRank™: iAnthus Capital scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for iAnthus Capital. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of iAnthus Capital is 0.03, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.59.Price to Earnings Ratio vs. SectorThe P/E ratio of iAnthus Capital is 0.03, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 30.26. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares ShortedShort Interest Ratio / Days to CoveriAnthus Capital has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in iAnthus Capital has recently decreased by 99.57%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldiAnthus Capital does not currently pay a dividend.Dividend GrowthiAnthus Capital does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares ShortedShort Interest Ratio / Days to CoveriAnthus Capital has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in iAnthus Capital has recently decreased by 99.57%, indicating that investor sentiment is improving significantly. News and Social Media1.8 / 5News Sentiment0.28 News SentimentiAnthus Capital has a news sentiment score of 0.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for iAnthus Capital this week, compared to 0 articles on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, iAnthus Capital insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.34% of the stock of iAnthus Capital is held by institutions.Read more about iAnthus Capital's insider trading history. Receive ITHUF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iAnthus Capital and its competitors with MarketBeat's FREE daily newsletter. Email Address ITHUF Stock News HeadlinesiAnthus Capital Holdings, Inc.: iAnthus Reports Second Quarter 2025 Financial ResultsAugust 13 at 8:18 AM | finanznachrichten.deiAnthus Reports Second Quarter 2025 Financial ResultsAugust 12 at 5:47 PM | financialpost.comFOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should buy in this market, this token might just be it.August 14 at 2:00 AM | Crypto 101 Media (Ad)iAnthus Reports Second Quarter 2025 Financial ResultsAugust 12 at 5:30 PM | globenewswire.comiAnthus Continues Expansion in Florida with GrowHealthy Dispensary of Palm HarborJuly 17, 2025 | financialpost.comFiAnthus Continues Expansion in Florida with GrowHealthy Dispensary of Palm HarborJuly 17, 2025 | financialpost.comFiAnthus Continues Expansion in Florida with GrowHealthy Dispensary of Palm HarborJuly 17, 2025 | globenewswire.comiAnthus Capital Holdings Inc (2IA.BE) - Yahoo FinanceJuly 11, 2025 | au.finance.yahoo.comSee More Headlines ITHUF Stock Analysis - Frequently Asked Questions How have ITHUF shares performed this year? iAnthus Capital's stock was trading at $0.0048 on January 1st, 2025. Since then, ITHUF shares have increased by 14.6% and is now trading at $0.0055. How do I buy shares of iAnthus Capital? Shares of ITHUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryAgriculture Current SymbolOTCMKTS:ITHUF CIK1643154 Webwww.ianthuscapital.com Phone646-518-9411FaxN/AEmployees1,000Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio0.04 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (OTCMKTS:ITHUF) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iAnthus Capital Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iAnthus Capital With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.